Standout Papers
Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
2015
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
2011 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Radiotherapy for renal-cell carcinoma
2014
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
2010
Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar Cholangiocarcinoma
2011
The treatment of brain metastases in melanoma patients
2004
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Stereotactic body radiation therapy: a novel treatment modality
2009
Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma
2011
Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors
2003
Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagonised brain metastases: results and implications
2002
Nasopharyngeal carcinoma
2019 Standout
Hepatocellular carcinoma
2021 Standout
Current Strategies in Whole-brain Radiation Therapy for Brain Metastases
2005
Colorectal cancer
2013 Standout
Headache related to brain tumors
2006
The oligometastatic state—separating truth from wishful thinking
2014
Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04
2001
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
The Role of Tumor Size in the Radiosurgical Management of Patients with Ambiguous Brain Metastases
2003
Pyroptosis: mechanisms and diseases
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review
2005
Detection and chemoradiotherapeutic evaluation of advanced esophageal squamous cell carcinoma using gallium-67 SPET: a preliminary study
2002
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
2013
Nasopharyngeal carcinoma
2015 Standout
Brain metastases: current management and new developments
2008
Malignant Gliomas in Adults
2008 Standout
Variable Selection for Propensity Score Models
2006 Standout
Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: Results and toxicity
2006
Linac Radiosurgery Versus Whole Brain Radiotherapy for Brain Metastases
2004
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003
2007
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
2019
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Risks of Neoadjuvant Chemotherapy and Radiation Therapy
2008
Local treatments for metastases of renal cell carcinoma: a systematic review
2014
Updates on esophageal and gastric cancers
2006
Stereotatic radiosurgery of 468 brain metastases ≤2 cm: implications for SRS dose and whole brain radiation therapy
2004
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice
2014
Orthotopic liver transplantation in combination with neoadjuvant therapy
2012
Hepatocellular carcinoma
2022 Standout
Special Treatment Issues in Non-small Cell Lung Cancer
2013
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
2002
Diffusion Changes in a Tumor and Peritumoral Tissue After Stereotactic Irradiation for Brain Tumors
2006 StandoutNobel
Recent Developments in the Econometrics of Program Evaluation
2009 StandoutNobel
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods
2005
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull
2003
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies
2008
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice
2014
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
2017
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases
2017
Works of Mark A. Chidel being referenced
Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer
2003
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma
2003
Resectable Esophageal Carcinoma: Local Control with Neoadjuvant Chemotherapy and Radiation Therapy
1999
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
2011
Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma
2002
Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis
1999
Stage III non–small cell lung cancer and metachronous brain metastases
2002
Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases
2000
Brain metastases: Presentation, evaluation, and management
2000
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
2009
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout